Descubra las mejores clínicas y precios para el tratamiento de Cáncer de ovarios en Corea del Sur 2026

Samsung Medical Center and Asan Medical Center are top-rated hospitals for ovarian cancer treatment in South Korea. These institutions hold JCI and ISO certifications and rank among the world's best for oncology. They offer advanced therapies like HIPEC, proton therapy, and robotic surgery.

• Samsung Medical Center: Ranked 3rd globally for oncology by Newsweek for advanced cancer care.
• Asan Medical Center: Performs the highest volume of gynecologic surgeries in South Korea annually.
• Seoul National University: Known for research-driven protocols and specialized fertility-sparing options for patients.
• Severance Hospital: JCI-accredited facility offering specialized international patient services and HIPEC expertise.

Bookimed Expert Insight: Korea University Anam Hospital offers a distinct advantage for patients concerned about surgical scarring. While many centers use the Da Vinci system, this hospital pioneered robotic techniques that reduce scar size by 90%. Their bloodless surgery protocols also contribute to faster recovery and lower infection risks for complex oncology cases.

Patient Consensus: Patients note that major Seoul hospitals offer significant savings compared to US treatment. They emphasize choosing a specific surgeon experienced in your cancer stage rather than just the hospital name.

South Korea offers ultra-modern ovarian cancer treatments including robotic-assisted debulking surgery and Hyperthermic Intraperitoneal Chemotherapy. Leading Seoul centers integrate genomic profiling to prescribe targeted PARP inhibitors and heavy ion therapy. Specialized oncology teams utilize the Da Vinci system to improve precision and accelerate recovery.

• Robotic surgery: Da Vinci systems allow precise tumor removal through minimal incisions.
• HIPEC protocol: Heated chemotherapy is applied during surgery to eliminate microscopic cancer cells.
• Heavy ion therapy: Carbon ion beams treat resistant tumors at Severance Hospital center.
• Targeted therapy: PARP inhibitors like Olaparib treat BRCA-positive cases following genetic testing.
• Immunotherapy trials: Major academic hospitals provide access to CAR-T and checkpoint inhibitor trials.

Bookimed Expert Insight: South Korea is a global leader in surgical technology, with Severance Hospital alone hosting over 2,000 specialist doctors. While many countries focus solely on chemotherapy, Korean centers like Korea University Anam Hospital pioneered robotic reconstructions. This heavy emphasis on robotic precision often results in significantly shorter hospital stays than traditional open-abdominal surgeries.

Patient Consensus: Patients emphasize the importance of early genetic testing in Korea to qualify for advanced clinical trials and PARP inhibitors. Many note that robotic debulking allowed them to return to work within four weeks and suggest using coordinators for English support.

South Korea reports a 65.9% overall 5-year relative survival rate for ovarian cancer. Localized cases show high success with survival reaching 92.5%. Advanced treatments including HIPEC and robotic surgery contribute to these outcomes. Most procedures are performed at JCI-accredited tertiary centers in Seoul.

• Localized survival: 5-year survival rates for localized tumors reach 90.7% to 92.5%.
• Regional survival: Survival for cancer spread to nearby organs is 72.8% to 74.7%.
• Surgical efficacy: Specialized oncology centers report an 85% to 90% surgical efficacy rate.
• Subtype outcomes: Clear cell carcinoma shows approximately 74.9% survival in Korean clinical reports.

Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 2 million yearly. This high frequency directly correlates with the 90% surgical success rates observed. Specialized centers like Korea University Anam Hospital even offer bloodless surgery protocols. These protocols help patients with personal or medical restrictions avoid transfusions during complex staging.

Patient Consensus: Patients emphasize the importance of getting second pathology reviews from multiple Seoul hospitals before surgery. Finding a surgeon experienced in cytoreductive techniques is often more important than the clinic brand itself.

Hospital stays for ovarian cancer surgery in South Korea typically range from 3 to 10 days. Minimally invasive robotic or laparoscopic procedures often allow discharge within 3 to 7 days. Complex cytoreductive surgeries for advanced cases may require 9 to 17 days of inpatient monitoring.

• Robotic surgery stay: Patients usually remain in the hospital for 6 to 7 days.
• Laparoscopic surgery stay: Hospitalization typically lasts between 3 and 4 days for many patients.
• Initial recovery: Light daily activities can generally be resumed within 4 to 6 weeks.
• Full recovery: Most patients return to all normal activities by 8 to 12 weeks.

Bookimed Expert Insight: Data from major hubs like Severance Hospital and Samsung Medical Center shows a trend toward ultra-fast mobilization. While standard debulking can take 10 days, top surgeons like Dr. Kim Young Tae utilize robotic systems to target 3-day stays. This efficiency allows international patients to transition to outpatient care faster than in many European centers.

Patient Consensus: Patients note that walking on the first day after surgery is highly encouraged to speed up discharge. Many suggest having translation apps ready to navigate the efficient, fast-paced hospital environment during their stay.